clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Sacroiliitis D058566 1 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Huet D et al. [Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. 2017 Rev Mal Respir pmid:27639948
Camara B et al. [Infection due to Mycobacterium malmoense in an immunocompetent patient]. 2008 Rev Mal Respir pmid:19106910
Schubel K et al. [Pleuropneumonia due to Mycobacterium chelonae]. 2011 Rev Mal Respir pmid:21482339
Dixmier A et al. [Pulmonary infections with Mycobacterium xenopi in patients without HIV infection]. 2007 Rev Mal Respir pmid:17417167
Frija-Masson J et al. [Non-tuberculous mycobacterial infection of a totally implanted perfusion device]. 2015 Rev Mal Respir pmid:25480387
Gomez-Abreo D et al. [Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]. 2012 Rev Mal Respir pmid:22440310
González C et al. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin]. 2001 Rev Med Chil pmid:11510204
Pavié G J et al. [Assessment of the management of community-acquired pneumonia in adults outpatients]. 2005 Rev Med Chil pmid:16446856
Sánchez H et al. [Compliance with guidelines for the management of community acquired pneumonia at primary health care centers]. 2009 Rev Med Chil pmid:20361133
Alvarez A et al. [Antimicrobial susceptibility of Helicobacter pylori strains isolated in Colombia]. 2009 Rev Med Chil pmid:20011937
Fariña N et al. [Antimicrobial susceptibility of H pylori strains obtained from Paraguayan patients]. 2007 Rev Med Chil pmid:17989858
García-Agudo L et al. [Assessment of in vitro susceptibility to antimicrobials of rapidly growing mycobacteria by E-test]. 2009 Rev Med Chil pmid:19802419
Vallejos C et al. [Prevalence of metronidazole, clarithromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients]. 2007 Rev Med Chil pmid:17505573
Poiată A et al. [Meropenem activity against staphylococci]. 2005 Jan-Mar Rev Med Chir Soc Med Nat Iasi pmid:16607852
Niang M et al. [Painful nodular lesions]. 1998 Rev Med Interne pmid:9793156
Cinquetti G et al. [Rare complications of Lemierre's syndrome: septic sternoclavicular joint arthritis and cavitating pneumonia]. 2009 Rev Med Interne pmid:19896753
Leclercq V et al. [Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine]. 2005 Rev Med Interne pmid:16023268
de Korwin JD [Helicobacter pylori infection and antimicrobial agents resistance]. 2004 Rev Med Interne pmid:14736561
Scheen AJ [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. 1998 Rev Med Liege pmid:9555183
Lutgen N et al. [Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege]. 2001 Rev Med Liege pmid:11256133
Guiot J et al. [Mycobacterium malmoense infection in an immunocompetent patient]. 2009 Jul-Aug Rev Med Liege pmid:19777918
Flores-Gonzalez JC et al. [Etiology, clinical presentation and outcome of severe viral acute childhood encephalitis (ECOVE study)]. 2015 Rev Neurol pmid:26108903
Dautzenberg B [Treatment of atypical mycobacterium infections: current state and therapeutic perspectives]. 1992 Rev Pneumol Clin pmid:1296257
Melo-Cristino J et al. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004. Rev Port Pneumol pmid:16572254
Bronstein JA [National ranking exam. N63. What could fall at the exam?]. 2008 Rev Prat pmid:18506983
Lamouliatte H et al. [Treatment of Helicobacter pylori infection]. 2000 Rev Prat pmid:11019637
Roche B et al. Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi. 1997 Rev Rhum Engl Ed pmid:9051864
Colomina Rodríguez J et al. [Impact of Integrated Model for Rational Use of Antibiotics in a health area (project MIURA)]. Rev. Esp. Salud Publica pmid:20661527
Ramzy I et al. GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS. 2016 Rev. Inst. Med. Trop. Sao Paulo pmid:27982354
Picoli SU et al. Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients. 2014 May-Jun Rev. Inst. Med. Trop. Sao Paulo pmid:24878996
Vianna JS et al. The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. 2018 Rev. Inst. Med. Trop. Sao Paulo pmid:29972462
Estrada-Gómez RA et al. Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico. 2007 Mar-Apr Rev. Invest. Clin. pmid:17633798
Leal YA et al. A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy. 2008 Nov-Dec Rev. Invest. Clin. pmid:19378833
Gutiérrez-Castrellón P et al. Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. 2012 Mar-Apr Rev. Invest. Clin. pmid:22991774
Gélisse P et al. [Carbamazepine and clarithromycin: a clinically relevant drug interaction]. 2007 Rev. Neurol. (Paris) pmid:18033049
Dalston MO et al. [Clarithromycin combined with pyrimethamine in cerebral toxoplasmosis--a report of 2 cases]. 1995 Oct-Dec Rev. Soc. Bras. Med. Trop. pmid:8668843
Caliskan R et al. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. Rev. Soc. Bras. Med. Trop. pmid:26108005
Paina FA et al. [Hematological, hemostatic and biochemical alterations induced by clofazimine and clarithromycin, in single and multiple doses, in rats]. 2008 May-Jun Rev. Soc. Bras. Med. Trop. pmid:18719809
Andereya S et al. Reactive knee and ankle joint arthritis: abnormal manifestation of Legionella pneumophila. 2004 Rheumatol. Int. pmid:14513269
Cohen O et al. Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori. 2015 Rheumatol. Int. pmid:26210999
Saviola G et al. Clarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value--a 24-month single-blind pilot study. 2013 Rheumatol. Int. pmid:23864141
Breda L et al. Non-tuberculous mycobacterial osteomyelitis: an unusual cause of hip pain in immunocompetent children. 2009 Rheumatol. Int. pmid:19156420
Saviola G et al. Clarithromycin in adult-onset Still's disease: a study of 6 cases. 2010 Rheumatol. Int. pmid:20033412
O'Connor MB et al. Rituximab-induced pulmonary disease. 2012 Rheumatol. Int. pmid:21892654
Haj Yahia S et al. Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. 2018 Rheumatol. Int. pmid:28975396
Furuya H et al. SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody. 2017 Rheumatology (Oxford) pmid:28371927
Cervin A and Wallwork B Macrolide therapy of chronic rhinosinusitis. 2007 Rhinology pmid:18085018
Stefansson P et al. Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. 1998 Rhinology pmid:9923060
Haruna S et al. A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. 2009 Rhinology pmid:19382498
Murata Y et al. [Study on the detection methods of Helicobacter pylori from clinical specimens]. 2002 Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi pmid:11895427